Canada markets close in 1 hour 7 minutes
  • S&P/TSX

    19,059.17
    -163.57 (-0.85%)
     
  • S&P 500

    3,813.45
    -8.10 (-0.21%)
     
  • DOW

    31,010.23
    +63.24 (+0.20%)
     
  • CAD/USD

    0.7757
    -0.0012 (-0.15%)
     
  • CRUDE OIL

    109.74
    -2.02 (-1.81%)
     
  • BTC-CAD

    25,859.90
    -539.86 (-2.04%)
     
  • CMC Crypto 200

    431.79
    -7.87 (-1.79%)
     
  • GOLD FUTURES

    1,820.50
    -0.70 (-0.04%)
     
  • RUSSELL 2000

    1,715.61
    -23.23 (-1.34%)
     
  • 10-Yr Bond

    3.1040
    -0.1020 (-3.18%)
     
  • NASDAQ

    11,144.04
    -37.50 (-0.34%)
     
  • VOLATILITY

    28.38
    +0.02 (+0.07%)
     
  • FTSE

    7,312.32
    -11.09 (-0.15%)
     
  • NIKKEI 225

    26,804.60
    -244.87 (-0.91%)
     
  • CAD/EUR

    0.7425
    +0.0089 (+1.21%)
     

Aurora Spine Corporation Schedules Release for Fourth Quarter and Fiscal Year 2021 Financial Results and Conference Call

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
Aurora Spine Corporation
Aurora Spine Corporation

CARLSBAD, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release for the fourth quarter ended December 31, 2021, on Friday, April 29, 2022. Management will host a conference call on Monday, May 2, 2022 at 11:00 a.m. Eastern Time to discuss the results with investors.

Fourth Quarter 2021 Conference Call Details

Date and Time: Monday, May 2, 2022, at 11:00 a.m. ET

Call-in Information: Interested parties can access the conference call by dialing (844) 861-5497 or (412) 317-5794.

Webcast: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company's website at https://www.aurora-spine.com/investors-v02 or via the following link: https://app.webinar.net/q7jDAGmNKQY.

Replay: A teleconference replay of the call will be available until May 9, 2022, at (877) 344-7529 or (412) 317-0088, replay access code 3855078. Additionally, a replay of the webcast will be available in the Investor Relations section of the Company's website at https://www.aurora-spine.com/investors-v02 or at https://app.webinar.net/q7jDAGmNKQY for 90 days.

About Aurora Spine

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

Contact:

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Chad Clouse
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com

Adam Lowensteiner
LYTHAM PARTNERS, LLC
Phoenix | New York
Telephone: 646-829-9700
asapf@lythampartners.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting